FPT-SOFTWARE
FPT Software, Vietnam’s leading IT solutions provider, recently announced the opening of its first office in the Scandinavian region and the 59th office internationally.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220905005353/en/
From left to right, FPT Software Europe CEO, Mr. Le Hai; FPT Corporation Chairman, Dr. Truong Gia Binh; Denmark’s State Secretary for Trade and Global Sustainability, H.E. Ms. Lina Gandløse Hansen; Vietnamese Ambassador to Denmark, H.E. Mr. Luong Thanh Nghi; Vido Group Founder, Ms. Nguyen Tuyet Mai; Vido Group Denmark CEO, Mr. Jesper G. Jensen. (Photo by Vietnam News Agency)
Within the framework of the Vietnam - Denmark Business Forum, FPT Software and Vido Group, Vietnam’s leading travel services provider, had a joint ribbon-cutting ceremony, marking both companies’ first footprint in Denmark. The event was hosted by the Embassy of Vietnam in Denmark, FPT Software and Vido Group, and was attended by Denmark’s State Secretary for Trade and Global Sustainability, H.E. Ms. Lina Gandløse Hansen, Vietnamese Ambassador to Denmark, H.E. Mr. Luong Thanh Nghi, and executives from Vietnam and Denmark’s companies.
The new office extends FPT Software’s presence in Europe to seven countries and aims at exploring opportunities for sustainable and innovative business growth. It is located in Kongens Lyngby, a commercial area and home to major companies, including Microsoft, COWI A/S, Bang & Olufsen, among others.
“Denmark is one of Vietnam’s largest foreign investors. As Vietnam’s leading corporation, FPT believes that with this newly opened office, we could contribute to strengthening the relationship between the two countries and act as a bridge between both sides’ businesses," FPT Chairman, Dr. Truong Gia Binh said. “We are committed to accompanying Danish and other Nordic customers with our investments, digital technologies, and talents,” he pledged.
“I am very pleased to see FPT Software, a Vietnamese pioneering company in IT services, open its representative office in Denmark. This is the first time a big Vietnamese enterprise has set foot in the Danish market, one with very high standards. FPT Software's presence in Denmark, one of the world's leading countries in technology and digital transformation, has shown that Vietnamese businesses can fully reach out to the world,” Vietnamese Ambassador to Denmark Luong Thanh Nghi said.
“I believe that the presence of enterprises like FPT in Denmark or Carlsberg and LEGO in Vietnam will contribute to promoting, strengthening, and deepening the comprehensive partnership between Vietnam and Denmark. The Embassy of Vietnam in Denmark is committed to supporting and serving the interests of the people and businesses of the two countries,” Vietnamese Ambassador to Denmark Luong Thanh Nghi added.
The ceremony was followed by two panel discussions on how businesses and governments of Vietnam and Denmark can cooperate to promote digital transformation and green transition, as demonstrated by successful cases and experiences from top enterprises like LEGO, Covestro, and Schaeffler. As the Head of the Private Economic Development Research Board under the Government's Advisory Council on Administrative Procedure Reform, Dr. Truong Gia Binh also shared his insights on these matters.
Scandinavia has been at the forefront of digital transformation. Being the region’s success story, the Danish Government recently launched a new digitalization strategy in May 2022 with the vision to accelerate green transition, increase growth, talents, and exports with digital innovations. This provides foreign investors in such fields as AI, Fintech, Robotics, among others, with opportunities to expand in Scandinavia. With the new office in Denmark, FPT Software can extend its support to organizations in the region to address their demands on digital talent and emerging technologies.
The newly inaugurated office asserts FPT Software’s rapid growth and a strong commitment to expanding its European team. 2022 marks FPT Software’s 10th year of operation in Europe. After a decade, FPT Software Europe currently has 500 employees working across seven countries in the region and serves a clientele of nearly 100 organizations, including RWE, Schaeffler, Airbus, E.ON, and more. The company sets sights on becoming one of the Top 10 Digital Transformation services providers in Europe by 2025.
About FPT Software
FPT Software is a global technology and IT services provider headquartered in Vietnam, with more than USD 632.5 million in revenue and 25,500 employees in 28 countries. As a pioneer in digital transformation, the company delivers world-class services in Smart factory, Digital platforms, RPA, AI, IoT, Cloud, AR/VR, BPO, and more. It has served 1,000+ customers worldwide, a hundred of which are Fortune Global 500 companies in the industries of Automotive, Banking and Finance, Logistics & Transportation, Utilities, and more. For further information, please visit http://www.fpt-software.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220905005353/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom